CN102665762A - 膜状药物剂型 - Google Patents
膜状药物剂型 Download PDFInfo
- Publication number
- CN102665762A CN102665762A CN2010800531265A CN201080053126A CN102665762A CN 102665762 A CN102665762 A CN 102665762A CN 2010800531265 A CN2010800531265 A CN 2010800531265A CN 201080053126 A CN201080053126 A CN 201080053126A CN 102665762 A CN102665762 A CN 102665762A
- Authority
- CN
- China
- Prior art keywords
- film
- dosage form
- weight
- copolymer
- film former
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physiology (AREA)
- Pulmonology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Otolaryngology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09176929 | 2009-11-24 | ||
EP09176929.9 | 2009-11-24 | ||
US26425909P | 2009-11-25 | 2009-11-25 | |
US61/264,259 | 2009-11-25 | ||
PCT/EP2010/067384 WO2011064111A1 (fr) | 2009-11-24 | 2010-11-12 | Formes posologiques pharmaceutiques de type film |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102665762A true CN102665762A (zh) | 2012-09-12 |
Family
ID=43334373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010800531265A Pending CN102665762A (zh) | 2009-11-24 | 2010-11-12 | 膜状药物剂型 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20120244197A1 (fr) |
EP (1) | EP2504033A1 (fr) |
JP (1) | JP2013511565A (fr) |
CN (1) | CN102665762A (fr) |
WO (1) | WO2011064111A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104971045A (zh) * | 2014-04-11 | 2015-10-14 | 上海宣泰医药科技有限公司 | 泊沙康唑药物组合物及其制备方法和药物制剂 |
CN116617193A (zh) * | 2023-07-10 | 2023-08-22 | 北京丰科睿泰医药科技有限公司 | 一种吡仑帕奈口溶膜剂 |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8790703B2 (en) * | 2009-03-31 | 2014-07-29 | Basf Se | Method for producing preparations of substances poorly soluble in water |
US8715729B2 (en) | 2010-12-22 | 2014-05-06 | Basf Se | Rapidly disintegrating, solid coated dosage form |
CA2844008A1 (fr) | 2011-08-01 | 2013-02-07 | Ranbaxy Laboratories Limited | Systeme d'administration de medicaments a liberation controlee et dissolution amelioree pour medicaments peu solubles dans l'eau |
EP2572731A1 (fr) * | 2011-09-26 | 2013-03-27 | Abbott GmbH & Co. KG | Formulations à base de dispersions solides |
CA2919442A1 (fr) * | 2013-07-31 | 2015-02-05 | Intelgenx Corp. | Forme posologique orale en film instantanement mouillable sans tensioactif ni polyol |
US20160193151A1 (en) * | 2015-01-06 | 2016-07-07 | Maria Del Pilar Noriega Escobar | Dosage form incorporating an amorphous drug solid solution |
CZ307444B6 (cs) * | 2015-04-22 | 2018-08-29 | Jakub Rak | Mukoadhezivní polymerní film pro fotosenzitivní terapii v ústní dutině s obsahem fotosenzitizérů |
ES2881435T3 (es) * | 2015-10-23 | 2021-11-29 | Basf Se | Soluciones sólidas de sustancias odorantes y aromatizantes con polímeros de vinilactama |
US20210128439A1 (en) * | 2017-08-03 | 2021-05-06 | Morinaga Milk Industry Co., Ltd. | Edible Film |
EP3668505A4 (fr) | 2017-08-15 | 2021-05-12 | Nephron Pharmaceuticals Corporation | Composition de nébulisation aqueuse |
DE102017127452A1 (de) * | 2017-11-21 | 2019-05-23 | Lts Lohmann Therapie-Systeme Ag | Wasserlösliche Polymerklebschichten |
JP7459458B2 (ja) * | 2018-06-28 | 2024-04-02 | ライオン株式会社 | 内服組成物及びその製造方法 |
DE102019202570A1 (de) * | 2019-02-26 | 2020-08-27 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verfahren zum Erhalt von Fucoxanthin und Fettsäuren aus Algenbiomasse |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5512293A (en) * | 1992-07-23 | 1996-04-30 | Alza Corporation | Oral sustained release drug delivery device |
WO2007051743A2 (fr) * | 2005-11-04 | 2007-05-10 | Basf Se | Utilisation de copolymeres en tant que solubilisants de composes peu solubles dans l'eau |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19814730A1 (de) * | 1998-04-02 | 1999-10-07 | Basf Ag | Verwendung von N-Vinyllacram oder N-Vinylamin haltigen Copolymeren als Matrix zur Herstellung von festen pharmazeutischen und kosmetischen Darreichungsformen |
US8658201B2 (en) * | 2004-01-30 | 2014-02-25 | Corium International, Inc. | Rapidly dissolving film for delivery of an active agent |
DE102004049740B4 (de) * | 2004-10-13 | 2009-08-27 | Lts Lohmann Therapie-Systeme Ag | Selbstklebende Zahnfolie und Verfahren zur Herstellung der Zahnfolie |
US20100204425A1 (en) | 2007-07-26 | 2010-08-12 | Basf Se | Process for preparing copolymers obtained by graft polymerization in solution and based on polyethers in solid form |
-
2010
- 2010-11-12 WO PCT/EP2010/067384 patent/WO2011064111A1/fr active Application Filing
- 2010-11-12 CN CN2010800531265A patent/CN102665762A/zh active Pending
- 2010-11-12 JP JP2012540358A patent/JP2013511565A/ja not_active Withdrawn
- 2010-11-12 EP EP10776706A patent/EP2504033A1/fr not_active Withdrawn
- 2010-11-12 US US13/511,759 patent/US20120244197A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5512293A (en) * | 1992-07-23 | 1996-04-30 | Alza Corporation | Oral sustained release drug delivery device |
WO2007051743A2 (fr) * | 2005-11-04 | 2007-05-10 | Basf Se | Utilisation de copolymeres en tant que solubilisants de composes peu solubles dans l'eau |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104971045A (zh) * | 2014-04-11 | 2015-10-14 | 上海宣泰医药科技有限公司 | 泊沙康唑药物组合物及其制备方法和药物制剂 |
US10022373B2 (en) | 2014-04-11 | 2018-07-17 | Sinotherapeutics Inc. | Posaconazole pharmaceutical compositions and preparation methods, uses and pharmaceutical formulations thereof |
CN116617193A (zh) * | 2023-07-10 | 2023-08-22 | 北京丰科睿泰医药科技有限公司 | 一种吡仑帕奈口溶膜剂 |
CN116617193B (zh) * | 2023-07-10 | 2024-01-30 | 北京丰科睿泰医药科技有限公司 | 一种吡仑帕奈口溶膜剂 |
Also Published As
Publication number | Publication date |
---|---|
EP2504033A1 (fr) | 2012-10-03 |
JP2013511565A (ja) | 2013-04-04 |
WO2011064111A1 (fr) | 2011-06-03 |
US20120244197A1 (en) | 2012-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102665762A (zh) | 膜状药物剂型 | |
JP4850346B2 (ja) | 粘膜貼付剤 | |
US8840935B2 (en) | Orally administrable films and preparation thereof | |
JP4838723B2 (ja) | 医薬又は化粧用薬剤を送達するための迅速分解性フイルム | |
JP4619894B2 (ja) | 粘膜表面への、薬剤化合物の送達に適する薬剤キャリアデバイス | |
JP4213383B2 (ja) | 活性成分を急速放出するための親水性ポリマーの薄膜状多層薬剤 | |
US8840919B2 (en) | Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films | |
US9248146B2 (en) | Dissolvable adhesive films for delivery of pharmaceutical or cosmetic agents | |
US6552024B1 (en) | Compositions and methods for mucosal delivery | |
CN103596551B (zh) | 含有用于掩味的离子交换树脂的食用口服条或糯米纸囊剂型 | |
US10092651B2 (en) | High-content fast dissolving film with masking of bitter taste comprising sildenafil as active ingredient | |
KR101148470B1 (ko) | 구강점막용 펜타닐 함유 패치 | |
WO2008112124A2 (fr) | Films administrables par voie orale | |
JP2001508037A (ja) | 粘膜表面への、薬学的化合物の送達に適する薬学的キャリアデバイス | |
JPH07553B2 (ja) | フイルム状製剤 | |
US20100041703A1 (en) | Rapid disintegration monolayer film for the oral administration of active substances | |
JP2024522779A (ja) | マクロライドの非ナノ粒子適用形態 | |
US20140271787A1 (en) | Continuous single layer film structure including discrete domains | |
EP2889030A1 (fr) | Contrôler les taux d'érosion de dispositifs muco-adhésifs qui fournissent des actifs et d'autres composés et fournir des niveaux sanguins thérapeutiques variables et accrus | |
TWI612978B (zh) | 口溶膜 | |
KR101489752B1 (ko) | 도세탁셀 약물을 함유하는 구강 용해 필름형 항암제 | |
Alsaide et al. | Insights into medicated films as attractive dosage forms | |
Joshi et al. | REPURPOSING MUCOADHESIVE DRUG DELEVERY SYSTEM: ADVANCEMENTS AND FUTURE PROSPECTS | |
rights are reserved by Moataz et al. | Creation and Assessment of Buccal Mucoadhesive Sustained Release Oral Films |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120912 |